China Holds All the Cards in Global Pharmaceuticals

China Holds All the Cards in Global Pharmaceuticals
That’s a potential supply-chain chokepoint that Washington has overlooked: its strategic rival’s tight grip on the raw materials needed to make an array of medicines. The urgency of tackling pharmaceutical supplies lies at the heart of the US-China Economic and Security Review Commission’s annual report, published last week. It proposed that Congress immediately amend a 2020 law to expand the... ...

Similar news